Breaking News Instant updates and real-time market news.

AMAG

Amag Pharmaceuticals

$20.70

(0.00%)

04:55
07/11/18
07/11
04:55
07/11/18
04:55

Amag Pharmaceuticals management to meet with Jefferies

Meetings to be held in New York on July 10 and in Boston on July 11 hosted by Jefferies.

  • 11

    Jul

  • 23

    Mar

AMAG Amag Pharmaceuticals
$20.70

(0.00%)

06/15/18
06/15/18
DOWNGRADE
Target $20

Neutral
Amag downgraded to Neutral from Buy at Janney Montgomery Scott
As previously reported, Janney Montgomery Scott analyst Ken Trbovich downgraded Amag Pharmaceuticals to Neutral from Buy after the company announced it has agreed to divest Cord Blood Registry to a private equity investment firm for $530M in cash. The sale loses a positive contributor for the company at a price below which CBR was acquired, said Trbovich, who maintains a $20 fair value estimate on Amag shares, which are down about 5% to $23.60 in morning trading.
06/15/18
RILY
06/15/18
UPGRADE
RILY
Buy
Amag Pharmaceuticals upgraded to Buy from Neutral at B. Riley FBR
06/15/18
06/15/18
UPGRADE
Target $30

Buy
Amag Pharmaceuticals upgraded to Buy after deal to sell CBR at B. Riley FBR
As previously reported, B. Riley FBR analyst David Buck upgraded Amag Pharmaceuticals to Buy from Neutral after the company agreed to sell Cord Blood Registry to private equity firm GI Partners for $530M in cash. The divestiture should allow the company to retire senior debt and become net debt free, which would eliminate his concern about Amag being highly-leveraged, Buck tells investors. Despite the "negative optics" of selling for below the $700M it paid to buy CBR, Buck sees the choice to divest as strategically sound, the analyst added. He raised his price target on Amag shares to $30 from $23, citing switching to Makena auto-injector, growth for Intrarosa and an early 2019 FDA approval for bremalanotide as key catalysts.
06/25/18
PIPR
06/25/18
NO CHANGE
Target $20
PIPR
Neutral
Piper Jaffray remains on sidelines after AMAG indicates launch of generic Makena
Piper Jaffray analyst Christopher Raymond maintained a Neutral rating and $20 price target on AMAG Pharmaceuticals after the company announced this morning that it intends to launch an authorized generic of Makena through generic manufacturer Prasco Laboratories, adding that Makena's loss of exclusivity "is now upon us." While he contends that the timing of the generic's approval "should surprise nobody," Raymond says this serves as a reminder to investors that a key threat to the business is now underway and remains on the sidelines. The analyst continues to model Makena revenue of $302M, $178M, $92M, and $29M for 2018-2021, adding that "the trajectory doesn't look pretty."

TODAY'S FREE FLY STORIES

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$104.35

-0.3 (-0.29%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 05

    Sep

  • 06

    Sep

FOXA

21st Century Fox

$46.01

-0.54 (-1.16%)

07:29
07/23/18
07/23
07:29
07/23/18
07:29
Conference/Events
21st Century Fox to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

SNAP

Snap

$13.27

-0.155 (-1.16%)

, SQ

Square

$70.41

0.11 (0.16%)

07:28
07/23/18
07/23
07:28
07/23/18
07:28
Periodicals
Snap to shutdown Snapcash, end partnership with Square, TechCrunch reports »

Snap (SNAP) will end its…

SNAP

Snap

$13.27

-0.155 (-1.16%)

SQ

Square

$70.41

0.11 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 07

    Aug

  • 15

    Aug

  • 16

    Aug

EVER

EverQuote

$17.99

0.43 (2.45%)

07:28
07/23/18
07/23
07:28
07/23/18
07:28
Initiation
EverQuote initiated  »

EverQuote initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

VFC

VF Corp.

$92.95

3.74 (4.19%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Recommendations
VF Corp. analyst commentary  »

VF Corp. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$182.65

0.49 (0.27%)

, P

Pandora

$8.20

0.005 (0.06%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Initiation
Spotify, Pandora initiated  »

Spotify initiated with a…

SPOT

Spotify

$182.65

0.49 (0.27%)

P

Pandora

$8.20

0.005 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Aug

  • 14

    Aug

SHOP

Shopify

$171.72

0.04 (0.02%)

07:27
07/23/18
07/23
07:27
07/23/18
07:27
Recommendations
Shopify analyst commentary  »

Shopify price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

BIIB

Biogen

$358.72

0.55 (0.15%)

07:26
07/23/18
07/23
07:26
07/23/18
07:26
Recommendations
Biogen analyst commentary  »

Biogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

07:25
07/23/18
07/23
07:25
07/23/18
07:25
General news
FX Update: The Dollar recovered losses »

FX Update: The Dollar…

GDDY

GoDaddy

$78.49

0.25 (0.32%)

07:24
07/23/18
07/23
07:24
07/23/18
07:24
Recommendations
GoDaddy analyst commentary  »

GoDaddy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EVER

EverQuote

$17.99

0.43 (2.45%)

07:23
07/23/18
07/23
07:23
07/23/18
07:23
Initiation
EverQuote initiated  »

EverQuote initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

WCG

WellCare

$256.13

0.545 (0.21%)

07:22
07/23/18
07/23
07:22
07/23/18
07:22
Initiation
WellCare initiated  »

WellCare initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

MOH

Molina Healthcare

$106.16

0.64 (0.61%)

07:20
07/23/18
07/23
07:20
07/23/18
07:20
Initiation
Molina Healthcare initiated  »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 21

    Aug

07:20
07/23/18
07/23
07:20
07/23/18
07:20
General news
Treasury Market Outlook: Treasury yields have dipped lower »

Treasury Market Outlook:…

CNC

Centene

$135.45

0.175 (0.13%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Initiation
Centene initiated  »

Centene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 10

    Aug

  • 23

    Oct

  • 14

    Dec

OMER

Omeros

$19.63

-0.42 (-2.09%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Hot Stocks
Omeros initiates sales of Omidria in Europe, satisfies 'sunset clause' »

Omeros announced initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOVE

Lovesac

$20.84

0.07 (0.34%)

07:19
07/23/18
07/23
07:19
07/23/18
07:19
Initiation
Lovesac initiated  »

Lovesac initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BJ

BJ's Wholesale

$25.90

0.23 (0.90%)

07:17
07/23/18
07/23
07:17
07/23/18
07:17
Initiation
BJ's Wholesale initiated  »

BJ's Wholesale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$45.69

-0.5 (-1.08%)

07:16
07/23/18
07/23
07:16
07/23/18
07:16
Conference/Events
21st Century Fox to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

SESN

Sesen Bio

$1.86

-0.05 (-2.62%)

07:16
07/23/18
07/23
07:16
07/23/18
07:16
Initiation
Sesen Bio initiated  »

Sesen Bio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$20.81

0.19 (0.92%)

07:14
07/23/18
07/23
07:14
07/23/18
07:14
Hot Stocks
Intra-Cellular announces publication highlighting ITI-214 »

Intra-Cellular Therapies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYB

RYB Education

$21.21

-0.33 (-1.53%)

07:14
07/23/18
07/23
07:14
07/23/18
07:14
Initiation
RYB Education initiated  »

RYB Education initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$10.85

-0.575 (-5.03%)

07:13
07/23/18
07/23
07:13
07/23/18
07:13
Hot Stocks
Hi-Crush Partners raises quarterly distribution to 75c per unit »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

ACRE

Ares Commercial

$13.99

-0.05 (-0.36%)

07:13
07/23/18
07/23
07:13
07/23/18
07:13
Initiation
Ares Commercial initiated  »

Ares Commercial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.